Call Script for Aetna "Hi, I'm calling to check coverage for a prescription medication
Terms and conditions apply
This landmark study of over 17,000 adults with established cardiovascular disease and overweight or obesity without diabetes demonstrated a 20% reduction in major adverse cardiovascular events with semaglutide 2.4 mg compared to placebo
Access and Equity Issues The high cost of novel glucagon-like peptide-1 receptor agonist class agents often limits access and creates barriers to care [62]
Well guess what, tl;dr is here to give you the rundown on what you need to know to join in on that super nerdy pharmacy conversation happening at the bar after work (cmon, you know you all do it)
January 2, 2025: More People File Ozempic Lawsuits Ahead of 2025 As of January 2, 2025, there are 1,331 pending lawsuits against GLP-1 drug manufacturers as part of federal, consolidated litigation